CJC-1295 + Ipamorelin Peptide Blend
CJC + IPA is a peptide combination supplied for research and analytical purposes. It is designed
for in vitro study by qualified professionals and not intended for human or medical application.
£39.99
Description
The CJC-1295 + Ipamorelin blend combines two research peptides commonly studied together
for their potential synergistic effects on growth hormone (GH) secretion pathways.
CJC-1295 is a synthetic analogue of Growth Hormone Releasing Hormone (GHRH) designed to
promote sustained GH release by extending the peptide’s half-life through DAC (Drug Affinity
Complex) binding.
Ipamorelin is a selective Growth Hormone Secretagogue (GHS) that mimics ghrelin’s activity to
stimulate GH release without significantly affecting cortisol or prolactin levels.
When used together in research models, these peptides are studied for their complementary
actions on GH pulsatility, metabolic processes, and cellular recovery mechanisms.
Molecular Information:
● CJC-1295: C₁₆₅H₂₇₁N₄₇O₄₆ — Molecular Weight 3647.1 g/mol
● Ipamorelin: C₃₈H₄₉N₉O₅ — Molecular Weight 711.9 g/mol
● CJC-1295: C₁₆₅H₂₇₁N₄₇O₄₆ — Molecular Weight 3647.1 g/mol
● Ipamorelin: C₃₈H₄₉N₉O₅ — Molecular Weight 711.9 g/mol
Form
Lyophilised powder
Purity
≥ 99%
Storage
Store at -20°C, protected from light and moisture.
Intended Use
For laboratory research use only. Not for human consumption, medical, or veterinary
use.
